Harrow, Inc. (HROW)
36.17
-3.05
(-7.78%)
USD |
NASDAQ |
Mar 05, 16:00
35.97
-0.20
(-0.55%)
Pre-Market: 08:20
Harrow Cash from Investing (TTM) : -5.46M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Corcept Therapeutics, Inc. | 69.76M |
| Regeneron Pharmaceuticals, Inc. | -629.10M |
| Xeris Biopharma Holdings, Inc. | -0.696M |
| Stoke Therapeutics, Inc. | -124.93M |
| Vir Biotechnology, Inc. | 310.37M |